Home /Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.

Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.

Submitted by dcc on Wed, 02/17/2016 - 12:47
TitleGynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.
Publication TypeJournal Article
Year of Publication2014
AuthorsHensley, ML, Barrette, BA, Baumann, KH, Gaffney, DK, Hamilton, AL, Kim, J-W, Maenpaa, JU, Pautier, P, Siddiqui, NAhmad, Westermann, AM, Ray-Coquard, I
JournalInt J Gynecol Cancer
Volume24
Issue9 Suppl 3
PaginationS61-6
Date Published11/2014
ISSN1525-1438
KeywordsCombined Modality Therapy, Consensus, Female, Humans, Leiomyosarcoma, Medical Oncology, Ovarian Neoplasms, Practice Guidelines as Topic, Societies, Medical, Uterine Neoplasms
Abstract

OBJECTIVES: The Gynecologic Cancer InterGroup aimed to provide an overview of uterine and ovarian leiomyosarcoma management.METHODS: Published articles and author experience were used to draft management overview. The draft manuscript was circulated to international members of the Gynecologic Cancer InterGroup for review and comment, and appropriate revisions were made.RESULTS: The approach to management of uterine and ovarian leiomyosarcoma management is reviewed.CONCLUSIONS: Uterine and ovarian leiomyosarcomas are rare and aggressive cancers that require specialized expertise for optimal management.
DOI10.1097/IGC.0000000000000261
Alternate JournalInt. J. Gynecol. Cancer
PubMed ID25341583
Grant ListU10 CA180818 / CA / NCI NIH HHS / United States